What Is Parkinson's Disease and How Does It Affect the Brain?

Parkinson's disease is a progressive neurological condition that affects how the brain controls movement. The disease occurs when nerve cells in a specific brain region called the substantia nigra begin to break down or die. These cells normally produce dopamine, a chemical messenger that helps coordinate smooth, controlled movements throughout your body.

How to Pay Your Mishawaka Utilities Bill →

When dopamine levels drop—typically by 60 percent or more before symptoms appear—a person begins to experience the hallmark movement problems associated with Parkinson's. The disease affects approximately 1 million people in the United States, with an average age of diagnosis around 60 years old, though younger people can develop it too.

The motor symptoms most people recognize include tremor (shaking, usually starting in one hand), rigidity (muscle stiffness), bradykinesia (slowness of movement), and postural instability (difficulty with balance and walking). However, Parkinson's impacts more than just movement. The same dopamine deficiency and changes in other brain chemicals affect cognition—the mental processes involved in thinking, memory, attention, and decision-making.

Brain imaging studies show that Parkinson's disease causes changes not only in the substantia nigra but also in other regions responsible for executive function, attention, and working memory. Over time, the disease can spread to additional brain areas, which helps explain why cognitive changes often accompany or follow motor symptoms. Research from the National Institute of Neurological Disorders and Stroke indicates that cognitive decline affects 24 to 31 percent of people with Parkinson's during the early stages, and this number increases as the disease progresses.

Practical takeaway: Understanding that Parkinson's affects the thinking brain as well as the moving brain helps individuals and families recognize early changes and seek appropriate evaluations and strategies.

Cognitive Changes in Parkinson's Disease: What to Recognize

Cognitive changes in Parkinson's disease vary widely among individuals. Some people experience minimal cognitive symptoms throughout their lives, while others notice significant changes that affect daily functioning. Recognizing these changes early is important because interventions and lifestyle modifications may help slow decline or manage symptoms more effectively.

Learn How to Make Payments to Capital One →

One of the most common cognitive changes is difficulty with executive function—the mental skills needed to plan, organize, multitask, and solve problems. A person might struggle to organize a grocery list, plan a household project, or juggle multiple tasks at once. Working memory—the ability to hold and manipulate information temporarily—often becomes affected. This might appear as difficulty following conversations or remembering what someone just said.

Attention and concentration difficulties are also frequent early cognitive changes. Someone might find it harder to focus on reading, television, or conversation, especially in distracting environments. Processing speed often slows, meaning it takes longer to think through problems or respond to questions. This is different from normal aging-related slowness and is often noticeable to family members who observe the person taking longer to answer questions or react to events.

The diagram below illustrates common cognitive domains affected in Parkinson's disease:

  • Executive Function: Planning, organizing, problem-solving, flexibility in thinking
  • Working Memory: Holding information temporarily while using it
  • Attention: Focusing on relevant information and filtering out distractions
  • Processing Speed: How quickly the brain processes information
  • Memory Retrieval: Retrieving stored information (often less affected than memory formation)
  • Visuospatial Skills: Perceiving and manipulating visual information and spatial relationships

Some people develop mild cognitive impairment (MCI) related to Parkinson's, meaning cognitive changes are noticeable but don't significantly interfere with daily activities. Others may eventually progress to Parkinson's disease dementia, which does substantially impact functioning. Approximately 24 percent of people with Parkinson's develop dementia within 8 years of diagnosis, though the timeline varies considerably.

Practical takeaway: Keeping a personal journal noting when cognitive difficulties occur, in what situations, and how they affect daily tasks provides valuable information to share with healthcare providers during evaluation and monitoring.

The Connection Between Parkinson's Medications and Cognition

The medications used to treat Parkinson's motor symptoms work by increasing dopamine levels in the brain or mimicking dopamine's effects. While these medications are essential for managing movement problems and improving quality of life, they sometimes affect cognition in complex ways. Understanding this relationship helps individuals and families make informed discussions with their healthcare team.

Learn About Green Card Costs and Fees →

Levodopa (L-DOPA), often combined with carbidopa or benserazide, is the gold standard medication for treating Parkinson's motor symptoms. It crosses the blood-brain barrier and converts to dopamine in the brain. Most research indicates that levodopa itself does not cause long-term cognitive decline and may actually help some cognitive functions by improving overall brain function and reducing motor symptoms that interfere with thinking tasks.

Dopamine agonists—medications that mimic dopamine's action—include medications like pramipexole, ropinirole, and rotigotine. These medications are sometimes associated with impulse control issues and in rare cases may affect attention or motivation. However, for most people, cognitive effects are minimal. Individual responses vary significantly.

Anticholinergic medications, older drugs like benztropine and trihexyphenidyl, have a clearer connection to cognitive effects. These medications block acetylcholine, another brain chemical involved in memory and attention. Studies show that anticholinergic medications can impair memory, attention, and mental processing speed, particularly in older adults. Many neurologists now recommend avoiding or minimizing anticholinergic medications in Parkinson's disease to preserve cognitive function.

Other medication classes used in Parkinson's include MAO-B inhibitors (selegiline, rasagiline), COMT inhibitors (entacapone, tolcapone), and amantadine. These medications generally have minimal cognitive effects, though individual variation exists. The timing of medication doses can also matter—some people notice that cognitive function is better when medication levels are optimized, as motor symptoms that create stress and cognitive load are better controlled.

Research from clinical trials shows that medication adjustments should always be made under medical supervision. Sometimes reducing doses of anticholinergic medications or adjusting dopamine agonist doses improves cognitive function. Other times, optimizing dopamine replacement actually enhances cognition. The relationship is individual and requires ongoing monitoring.

Practical takeaway: Keep detailed notes about cognitive symptoms in relation to medication timing and doses, and discuss any concerns about medication effects on thinking or memory with your neurologist, who can evaluate whether adjustments might help.

Lifestyle Strategies That May Support Brain Health in Parkinson's Disease

While medication is crucial for managing Parkinson's disease symptoms, research increasingly supports the role of lifestyle factors in supporting brain health and potentially slowing cognitive decline. These strategies work alongside medical treatment and may improve overall quality of life.

Learn About Receiving Venmo Payments to Your Email →

Physical exercise is among the most well-supported interventions. Studies published in neurology journals show that aerobic exercise, strength training, and balance exercises may benefit both motor and cognitive function in Parkinson's disease. Exercise increases blood flow to the brain, promotes the growth of new nerve cells, and increases levels of brain-derived neurotrophic factor (BDNF), a protein important for brain health. Research from the University of Illinois found that people with Parkinson's who engaged in moderate-intensity exercise showed slower cognitive decline than those who were sedentary. The recommendation from the American Parkinson Disease Association is at least 150 minutes of moderate-intensity aerobic activity weekly, plus resistance training and flexibility work.

Cognitive training and mental stimulation may help maintain thinking skills. Activities like puzzles, learning new skills, reading, writing, and engaging in intellectually demanding hobbies activate brain regions involved in memory and attention. While cognitive training doesn't prevent Parkinson's-related cognitive decline, it may help maintain function longer. A study in Neurology found that people who engaged in frequent cognitive activity showed later onset of cognitive decline compared to those with less mental stimulation.

Sleep quality significantly impacts cognition in Parkinson's disease. Sleep disturbances—including insomnia, REM sleep behavior disorder, and excessive